2',3'-diacetyluridine substituted with acetoacetyl at the 5' position

NZ836866APending Publication Date: 2026-09-25PHARMA CINQ LLC
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
NZ836866
Authority / Receiving Office
NZ · NZ
Patent Type
Applications
Current Assignee / Owner
Priority Date
2021-08-11
Filing Date
2021-09-14
Publication Date
2026-09-25

Smart Images

  • Figure 00000032_0000
    Figure 00000032_0000
  • Figure 00000033_0000
    Figure 00000033_0000
  • Figure 00000034_0000
    Figure 00000034_0000
Patent Text Reader

Abstract

5'-O-(Acetoacetyl)-2',3'-di-O-acetyluridine is useful in the treatment or prevention of disorders characterized by cerebral metabolic energy failure or diminished mitochondrial energy reserve capacity.
Need to check novelty before this filing date? Find Prior Art